Search All News
In people with dementia, delirium during COVID-19 is more common but deaths from COVID-19 are not disproportionately higher, finds a new study.
New research may lead to the development of drugs to prevent the nerve damage and pain many cancer patients experience during chemotherapy.
Cells used to study the human blood-brain barrier in the lab aren’t what they seem, a new study has found, throwing nearly a decade’s worth of research into question.
A new Columbia study suggests that malfunctioning endosomes—a central trafficking station inside neurons—are commonly involved in the appearance of Alzheimer’s disease.
- November 12, 2020
Ancient parts of the brain may hold secrets that help explain the drive to eat and how eating may affect brain health. Sabrina Diano, the new Institute of Human Nutrition director, is investigating.
- October 21, 2020
A new study of Alzheimer’s genes suggests the disease in Blacks and whites is largely the same, but genetic changes that increase the risk of developing the disease differ between the two groups.
- June 22, 2020
A newly discovered Alzheimer’s gene appears to drive the first appearance of amyloid plaque in the brain and could lead to new therapies that prevent the disease from developing.
- April 20, 2020
Seizures are usually considered a side effect of brain cancer, but a new Columbia University study of mice suggests they may also fuel the further growth of brain tumors.
- February 19, 2020
This July, Columbia neurologist Mitch Elkind will become president of the American Heart Association, only the second time a neurologist has led the organization.
- February 18, 2020
Patients taking the recommended diuretic for hypertension experienced more potentially serious side effects than those taking a similar drug, according to a new study from Columbia researchers.